Caroline Almon

403 total citations
8 papers, 61 citations indexed

About

Caroline Almon is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Caroline Almon has authored 8 papers receiving a total of 61 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Hematology and 2 papers in Genetics. Recurrent topics in Caroline Almon's work include Acute Myeloid Leukemia Research (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Caroline Almon is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Caroline Almon collaborates with scholars based in United States, France and Spain. Caroline Almon's co-authors include Salah Nabhan, Michael K. Cooper, Amir T. Fathi, Michael R. Savona, Eytan M. Stein, Courtney D. DiNardo, Bin Fan, Katharine Yen, Ashwin Kishtagari and Gerburg M. Wulf and has published in prestigious journals such as Nature Communications, Blood and Molecular Cancer Therapeutics.

In The Last Decade

Caroline Almon

8 papers receiving 60 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caroline Almon United States 6 39 34 11 10 9 8 61
Ronald F. Siebenaler United States 4 41 1.1× 37 1.1× 11 1.0× 5 0.5× 12 1.3× 6 65
Jason Van Oostendorp United Kingdom 2 40 1.0× 47 1.4× 10 0.9× 7 0.7× 12 1.3× 4 54
Kyle A. Romine United States 4 49 1.3× 46 1.4× 10 0.9× 19 1.9× 5 0.6× 8 82
Cecilia A. Castellano United States 2 74 1.9× 23 0.7× 8 0.7× 8 0.8× 14 1.6× 4 89
Tony Andreas Müller Germany 4 26 0.7× 29 0.9× 16 1.5× 13 1.3× 5 0.6× 7 64
Hana Cho United Kingdom 2 42 1.1× 24 0.7× 6 0.5× 6 0.6× 5 0.6× 4 55
Marek Milewski Poland 3 50 1.3× 33 1.0× 7 0.6× 6 0.6× 28 3.1× 5 69
Richard J. Bellin United States 2 48 1.2× 24 0.7× 7 0.6× 22 2.2× 4 0.4× 3 61
Maria Nieto Spain 4 46 1.2× 19 0.6× 4 0.4× 10 1.0× 7 0.8× 4 74
Adil Al Hinai Netherlands 3 41 1.1× 48 1.4× 6 0.5× 5 0.5× 13 1.4× 4 69

Countries citing papers authored by Caroline Almon

Since Specialization
Citations

This map shows the geographic impact of Caroline Almon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Almon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Almon more than expected).

Fields of papers citing papers by Caroline Almon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Almon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Almon. The network helps show where Caroline Almon may publish in the future.

Co-authorship network of co-authors of Caroline Almon

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Almon. A scholar is included among the top collaborators of Caroline Almon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Almon. Caroline Almon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Gounder, Mrinal M., Melissa L. Johnson, Rebecca S. Heist, et al.. (2025). MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial. Nature Communications. 16(1). 423–423. 8 indexed citations
2.
DiNardo, Courtney D., Michael R. Savona, Ashwin Kishtagari, et al.. (2023). Preliminary Results from a Phase 1 Dose Escalation Study of FHD-286, a Novel BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, Administered As an Oral Monotherapy in Patients with Advanced Hematologic Malignancies. Blood. 142(Supplement 1). 4284–4284. 10 indexed citations
3.
4.
Mason, Emily F., Olga Pozdnyakova, Mikhail Roshal, et al.. (2021). A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AML. Blood Advances. 5(8). 2279–2283. 5 indexed citations
5.
Fan, Bin, David L. Dai, Marvin B. Cohen, et al.. (2020). Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Oral Ivosidenib in Otherwise Healthy Participants. Clinical Pharmacology in Drug Development. 10(1). 99–109. 4 indexed citations
6.
Heist, Rebecca S., Mrinal M. Gounder, Sophie Postel‐Vinay, et al.. (2019). Abstract PR03: A phase 1 trial of AG-270 in patients with advanced solid tumors or lymphoma with homozygous MTAP deletion. Molecular Cancer Therapeutics. 18(12_Supplement). PR03–PR03. 5 indexed citations
7.
8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald F. Siebenaler Breakdown of academic impact, for papers by Jason Van Oostendorp Breakdown of academic impact, for papers by Kyle A. Romine Breakdown of academic impact, for papers by Cecilia A. Castellano Breakdown of academic impact, for papers by Tony Andreas Müller Breakdown of academic impact, for papers by Hana Cho Breakdown of academic impact, for papers by Marek Milewski Breakdown of academic impact, for papers by Richard J. Bellin Breakdown of academic impact, for papers by Maria Nieto Breakdown of academic impact, for papers by Adil Al Hinai
Rankless by CCL
2026